BELITE BIO, INC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.86 USD | -0.79% |
|
+4.49% | -6.32% |
Chart calendar Belite Bio, Inc
e390e0d6.BxdcdXMjPJADBG2aTUEVC8kpv8_SlZGfvhw4Y2AHmrA.bHAbTSJMW_suc13oLB5QU6Bj25e43cXuyVpoIQFIy9FGLi8FEkVOo3ZJXQ~c34ce69b837e135f0b375061dd8e056a
Upcoming events on Belite Bio, Inc
Past events on Belite Bio, Inc
| Today | Q1 2024 Earnings Release (Projected) |
| 2024-05-05 06:45 pm | Association for Research in Vision and Ophthalmology Meeting - Dr. John Grigg |
| 2024-03-13 10:00 am | Leerink Partners Global Biopharma Conference |
| 2024-03-12 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-11 09:27 pm | Q4 2023 Earnings Release |
| 2024-02-14 12:40 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2023-12-06 | Benchmark Company Discovery Conference |
| 2023-11-27 03:00 pm | BTIG Ophthalmology Day |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-13 08:15 pm | Q3 2023 Earnings Release |
| 2023-11-08 11:00 am | Deutsche Bank Depositary Receipts Virtual Investor Conference |
| 2023-11-05 06:57 pm | American Academy Of Ophthalmology Meeting |
| 2023-09-25 | Cantor Global Healthcare Conference |
| 2023-09-13 | H.C. Wainwright Global Investment Conference |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-08 10:17 pm | Q2 2023 Earnings Release |
| 2023-05-11 08:00 am | Q1 2023 Earnings Call |
| 2023-05-09 | Q1 2023 Earnings Release |
| 2023-05-03 01:00 pm | Investor Meeting - Key Opinion Leader |
| 2023-04-25 09:45 am | Association for Research in Vision and Ophthalmology Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 10,0 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,8 -13,5 5.27% | -31,7 -32,1 1.4% | -29,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,6 -13,4 5.88% | -31,6 -32,1 1.34% | -29,5 |
|
Net income Million USD | Released Forecast Spread | -9,67 | -12,6 -13,4 5.88% | -31,6 -32,8 3.64% | -22,9 |
|
EPS USD | Released Forecast Spread | -1,01 | -0,63 -0,66 3.82% | -1,19 -1,29 7.61% | -0,77 |
| Announcement Date | 15/03/22 | 31/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 12,5 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,78 -4,03 55.78% | -1,78 -4,73 62.33% | -4,35 | -5,63 | -6,88 -5,02 -37.07% | -6,87 -7,41 7.32% | -11,0 -8,38 -30.8% | -6,98 -7,43 6.1% | -7,50 | -7,07 | -7,57 | -6,90 | -6,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,73 -4,03 57.02% | -1,73 -4,73 63.39% | -4,35 | -5,63 | -6,89 -5,02 -37.22% | -6,81 -7,41 8.16% | -10,9 -8,38 -30.47% | -6,99 -7,43 5.89% | -7,50 | -7,07 | -7,57 | -6,90 | -6,50 |
|
Net income Million USD | Released Forecast Spread | -1,73 -4,03 57.02% | -1,73 -4,73 63.39% | -4,35 | -5,63 | -6,90 -5,02 -37.34% | -6,81 -7,44 8.38% | -10,9 -8,79 -24.47% | -6,99 -8,20 14.78% | -8,45 | -8,20 | -8,60 | 4,32 | -6,50 |
|
EPS USD | Released Forecast Spread | -0,12 -0,29 57.89% | -0,12 -0,24 48.94% | -0,18 | -0,23 | -0,33 -0,20 -65% | -0,26 -0,30 12.61% | -0,40 -0,32 -25% | -0,24 -0,30 20% | -0,29 | -0,28 | -0,29 | 0,16 | -0,20 |
| Announcement Date | 11/08/22 | 11/08/22 | - | - | 10/05/23 | 09/08/23 | 14/11/23 | 12/03/24 | - | - | - | - | - |
More events
Past sector events for Belite Bio, Inc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLTE Stock
- Calendar Belite Bio, Inc